Microarray

DNA Methylation Detection Technology Market Research 2024 - Global Forecast to 2033 Featuring Prominent Players - Thermo Fisher Scientific, Illumina, QIAGEN, Zymo Research, and Agilent Technologies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 2, 2024
Biotechnology, Genetics, Health, Diagnosis, PCR, Growth, Drug discovery, Thermo Fisher Scientific, Biomarker, Research, DNA, Competitive landscape, Real-time, Microarray, Cancer, Software, DNA methylation, Agilent Technologies, DSM-IV codes, QIAGEN, MSP, Prognosis, Marketing, Medicine, Fine chemical

The global DNA methylation detection technology market is projected to experience substantial growth over the forecast period 2023-2033.

Key Points: 
  • The global DNA methylation detection technology market is projected to experience substantial growth over the forecast period 2023-2033.
  • In the DNA methylation detection technology market, several key players dominate the landscape with their diverse range of products and solutions.
  • Thermo Fisher Scientific, Illumina, Inc. QIAGEN, Zymo Research Corporation, and Agilent Technologies, Inc. are among the prominent market players offering innovative tools and platforms for DNA methylation analysis.
  • The global DNA methylation detection technology market can be considered to be in the mature growth stage of its lifecycle.

DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates

Retrieved on: 
Saturday, March 30, 2024
Diagnosis, PCR, Health, Growth, Biotechnology, Drug discovery, Thermo Fisher Scientific, Biomarker, Research, DNA, Competitive landscape, Real-time, Microarray, Cancer, Software, DNA methylation, Agilent Technologies, DSM-IV codes, QIAGEN, MSP, Prognosis, Marketing, Medicine, Fine chemical

In the DNA methylation detection technology market, several key players dominate the landscape with their diverse range of products and solutions.

Key Points: 
  • In the DNA methylation detection technology market, several key players dominate the landscape with their diverse range of products and solutions.
  • Based on technology, the PCR segment accounted for the largest share of the global DNA methylation detection technology market in FY2022.
  • Moreover, PCR is expected to maintain its dominance in the global DNA methylation detection technology market by technology due to its widespread adoption, versatility, and reliability.
  • Based on application, diagnostic research accounted for the largest share of the global DNA methylation detection technology market in FY2022, primarily due to clinicians' increasing focus on utilizing DNA methylation analysis for clinical diagnostics.

Gene Expression (DNA Chip/Microarray, Kits & Reagents) Market Report 2023: Global Analysis and Forecasts by Technique, Capacity, Process, Application - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 29, 2023
Technology, Research, Genetics, Other Technology, Stem Cells, Biotechnology, Health, Other Science, Science, Gene expression, Hormone, DNA, Gene, Investment, Differentiable function, Application, Medicine, USD, Messenger, Nutrient, Genome, Budapest Metropolitan University, RNA, Capacity, Drug discovery, Growth, NGS, A-DNA, Temperature, Microarray, Process, Vaccine, Fine chemical, Agriculture

The "Gene Expression Market Size, Share & Trends Analysis Report By Product (DNA Chip/Microarray, Kits & Reagents), By Technique (Promoter Analysis, RNA Exp.

Key Points: 
  • The "Gene Expression Market Size, Share & Trends Analysis Report By Product (DNA Chip/Microarray, Kits & Reagents), By Technique (Promoter Analysis, RNA Exp.
  • ), By Capacity, By Process, By Application, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global gene expression market size is anticipated to reach USD 20.94 billion by 2030, registering a CAGR of 5.0% from 2023 to 2030.
  • In the post-genomic and epigenomic era, it is increasingly recognized that gene expression is not solely controlled by gene sequences.

Global SNP Genotyping Market: China Emerges as Key Growth Driver with 18.1% CAGR

Retrieved on: 
Thursday, August 24, 2023
Livestock, Compound annual growth rate, Microarray, SNP, SNP genotyping, Single-nucleotide polymorphism, Growth, Agricultural biotechnology, Breeding

DUBLIN, Aug. 23, 2023 /PRNewswire/ -- The "SNP Genotyping and Analysis: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 23, 2023 /PRNewswire/ -- The "SNP Genotyping and Analysis: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The market is expected to experience a robust Compound Annual Growth Rate (CAGR) of 18.8% over the analysis period from 2022 to 2030.
  • Among the key segments, SNP Genotyping by Microarrays and GeneChips is anticipated to exhibit strong growth with a projected CAGR of 22.3%, reaching $20.9 billion by the end of the analysis period.
  • This data aims to provide a comprehensive understanding of the trends, growth opportunities, and market dynamics in the global SNP Genotyping and Analysis industry across different geographic regions, methods, and applications.

PhenomeX Strengthens Commercial Leadership Team

Retrieved on: 
Tuesday, March 21, 2023
DNA, Bachelor, Cell biology, Bachelor of Science, Therapy, Senior, Doctor of Philosophy, Workflow, Medical college, Microarray, Cancer, Life Technologies, Molecular Devices, Thermo Fisher Scientific, CCO, North West Regional Leaders Board, Patient, CELL, Medical College of Wisconsin, Siddhartha, Yan, Growth, Eurofins Scientific, Management, Science, Biochemistry, Peking University, Affymetrix

EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang's appointment, PhenomeX also announced that Tomoya Aoyama has been named Regional Leader, overseeing the Company's commercial operations in APAC.

Key Points: 
  • In addition to Dr. Zhang's appointment, PhenomeX also announced that Tomoya Aoyama has been named Regional Leader, overseeing the Company's commercial operations in APAC.
  • With the combination of Berkeley Lights and IsoPlexis complete to form PhenomeX, Dr. Zhang will oversee a significantly expanded commercial organization with an enhanced geographical footprint.
  • "We are incredibly excited to welcome Dr. Zhang to PhenomeX, further strengthening our talented leadership team," said Siddhartha Kadia, Ph.D., chief executive officer of PhenomeX.
  • "I am thrilled to welcome Aoyama-san to the growing regional commercial teams at PhenomeX," concluded Dr. Kadia.

With a Two-Year Revenue Growth of 276%, PathogenDx Ranks No. 50 on Inc. Magazine's List of the Southwest Region's Fastest-Growing Private Companies

Retrieved on: 
Tuesday, February 28, 2023
USDA, Safety, Salmonella, Global health, Dog, Virus, Health, Deloitte Technology Fast 500, Database, Growth, Microarray, Inc., Mpox, Name, Mold, COVID-19, Cannabis, Airline, Vaccine

As Pathogens, Viruses and Superbugs Surge, the Microarray Technology Leader's Innovations Are Working to Address Some of the World's Most Urgent Challenges

Key Points: 
  • 50 on its fourth annual Inc. 5000 Regionals Southwest list1, the most prestigious ranking of the fastest-growing private companies based in Arizona, New Mexico, Oklahoma, and Texas.
  • "We are once again honored to be named as one of the fastest growing private companies in the Southwest," said PathogenDx Co-founder and CEO Milan Patel .
  • The companies on the Inc. 5000 Regionals Southwest list show a remarkable rate of growth across all industries in the Southwest region.
  • Between 2019 and 2021, these private companies added 16,116 jobs and nearly $5.5 billion to the Southwest region's economy.

Outlook on the RNA Analysis Global Market to 2028 - Featuring Illumina, Bio-Rad Laboratories, Eurofins Scientific and Merck Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Biotechnology, Genetics, Health, Classification, Genome, Gene expression, RNA, Phenotype, Toxicity, RNA transfection, DNA, Personalized medicine, Molecular biology, Orthornavirae, Microarray, Biomarker, Collection, Transcriptome, Research, Vaccine, Gene, Drug development, Protein, RNA-Seq, Application, MicroRNA, Drug discovery, Cancer, CVD, Data analysis, Real-time, Real, Toxicology, Healthcare

The Global RNA Analysis Market size is expected to reach $28 billion by 2028, rising at a market growth of 15.6% CAGR during the forecast period.

Key Points: 
  • The Global RNA Analysis Market size is expected to reach $28 billion by 2028, rising at a market growth of 15.6% CAGR during the forecast period.
  • The method used to produce RNA in a lab setting from a DNA template is known as in vitro transcription.
  • For use in procedures like in vitro translation, the investigation of RNA viruses, and RNA: protein interaction investigations, RNA is produced from DNA templates using in vitro transcription devices.
  • For use in RNA analysis research, single-stranded RNA probes, microgram amounts of specified RNA transcripts, and antisense RNA are all prepared using riboprobe systems.

Global Microarray Market Report 2022-2028: Rising Use of Microarrays to Diagnose Infectious Diseases Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, December 16, 2022
Health, Genetics, Geography, RNA, Agilent Technologies, Genetic testing, Diagnosis, Drug discovery, Prevalence, Government, Proteomics, DNA, Cancer, News, Prognosis, Gene expression, Conditional sentence, Microarray, Infection, Growth, Research, Amersham, Somatic mutation, Vaccine, Agriculture, Marketing

The global microarray market is anticipated to grow at a CAGR of around 7.8% during the forecast period.

Key Points: 
  • The global microarray market is anticipated to grow at a CAGR of around 7.8% during the forecast period.
  • Moreover, increasing prevalence of various chronic diseases and the rise of usage of microarrays technology for the diagnosis of such infectious diseases are also contributing to the growth of the microarray market.
  • On the basis of type, the market is segmented into DNA microarrays, protein microarray, peptide microarray, tissue microarray, and others (cellular microarray).
  • Among types, the DNA microarray segment is projected to have a significant share in the global microarray market.

Global Microarray Market Report 2022: Rise in the Usage of Microarrays in Various Applications Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, November 7, 2022
Other Health, Software, Research, Radiology, Pharmaceutical, Hardware, Technology, Genetics, Science, Biotechnology, Other Science, Health, Observation, Industry, Viral Research and Diagnostic Laboratories, Ansoff Matrix, Growth, Personal Software Services, CAGR, Academic institution, Market development, Geography, Software, Antibody microarray, USD, SWOT, Microarray, Drug discovery, Product, Medication, COVID-19, Biotechnology, Product-service system, Porter's five forces analysis, Risk, Medical device, Risk management, Pharmaceutical industry, Chemical substance, Application

By Type, the market is classified into Antibody Microarrays, Cellular Microarrays, Chemical compound Microarrays, DNA Microarrays, Peptide Microarrays, and Others.

Key Points: 
  • By Type, the market is classified into Antibody Microarrays, Cellular Microarrays, Chemical compound Microarrays, DNA Microarrays, Peptide Microarrays, and Others.
  • The report presents a detailed Ansoff matrix analysis for the Global Microarray Market.
  • The analyst analyses the Global Microarray Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Microarray Market.

Veterinary Diagnostics Market Report 2022: Growing Prevalence of Zoonotic Diseases to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, October 10, 2022
Veterinary, Health, Adoption, Veterinarian, Microbiology, Urbanization, Cat, Prevalence, Zoonosis, Growth, Diagnosis, Animal, ELISA, CAGR, APAC, Income, Medicine, Dog, Molecular diagnostics, PCR, Urine test strip, Awareness, Incidence, Hospital, USD, Livestock, Vaccine, Medical device, Pet, Technology, Cattle, Microarray, Hematology

The global veterinary diagnostics market is projected to reach USD 4.4 billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 9.2%.

Key Points: 
  • The global veterinary diagnostics market is projected to reach USD 4.4 billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 9.2%.
  • Based on technology, the veterinary diagnostics market is segmented into clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and other veterinary diagnostic technologies (includes microbiology and histopathology tests).
  • Clinical biochemistry analyzers are more commonly adopted in veterinary diagnostic laboratories, leading to a higher share in the veterinary diagnostics market.
  • Growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China, are contributing to the growth of the APAC veterinary diagnostics market.